Q4 2024 Earnings Call Transcript February 21, 2025 Operator: Good afternoon, and welcome to the Travere Therapeutics Fourth ...

We recently published a list of 10 Small–Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a ...

We recently published a list of These 10 Companies Led Tuesday’s Charge. In this article, we are going to take a look at ...

FOSTER CITY, Calif., February 11, 2025--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on ...

- 2024 net product sales of approximately $336 million exceeds upper end of guidance range; preliminary and unaudited estimate - 2025 expected global net product sales of $420 million to $435 ...

In the intestine BAs can be processed by the gut microbiota (8). Following an initial deconjugation the primary cholic acid (CA) is converted into deoxycholic acid (DCA) and chenodeoxycholic acid ...

Malnutrition is highly prevalent among patients with chronic liver disease and is nearly universal among patients awaiting liver transplantation. Malnutrition in patients with cirrhosis leads to ...

They are synthesized in the liver as primary BAs such as cholic acid (CA), chenodeoxycholic acid (CDCA) and conjugated forms. A variety of secondary BAs such as deoxycholic acid (DCA) and lithocholic ...

尊敬的新老客户：随着寒冬的脚步悄然临近，我们即将迎来中华民族最为盛大的传统节日——春节。为了让大家能够与家人共度一个欢乐、祥和的新春佳节，公司决定对2025年春节假期的安排进行如下通知：本次春节假期将 岁末年初，是我们回望过去、展望未来 ...